Dana-Farber’s Breast Oncology Center shared the following on X:
“Dr. Sara Tolaney discussed ESMO24 Insights in a new VuMedi video on the TroFuse-010 Trial – Sacituzumab Govitecan ± Pembro vs. Chemo in HR+/HER2- Advanced Breast Cancer.”
Dana-Farber’s Breast Oncology Center shared the following on X:
“Dr. Sara Tolaney discussed ESMO24 Insights in a new VuMedi video on the TroFuse-010 Trial – Sacituzumab Govitecan ± Pembro vs. Chemo in HR+/HER2- Advanced Breast Cancer.”